Pain and nociception: mechanisms of cancer-induced bone pain

S Falk, AH Dickenson - Journal of clinical oncology, 2014 - ascopubs.org
Cancer pain, especially pain caused by metastasis to bone, is a severe type of pain, and
unless the cause and consequences can be resolved, the pain will become chronic. As …

P2X receptor channels in chronic pain pathways

LP Bernier, AR Ase, P Séguéla - British journal of …, 2018 - Wiley Online Library
Chronic pain is a highly prevalent debilitating condition for which treatment options remain
limited for many patients. Ionotropic ATP signalling through excitatory and calcium …

Delayed activation of spinal microglia contributes to the maintenance of bone cancer pain in female Wistar rats via P2X7 receptor and IL-18

Y Yang, H Li, TT Li, H Luo, XY Gu, N Lü… - Journal of …, 2015 - Soc Neuroscience
Accumulating evidence suggests that activation of spinal microglia contributes to the
development of inflammatory and neuropathic pain. However, the role of spinal microglia in …

Pharmacological treatment of neuropathic cancer pain: a comprehensive review of the current literature

A Vadalouca, E Raptis, E Moka, P Zis, P Sykioti… - Pain …, 2012 - Wiley Online Library
Neuropathic cancer pain (NCP), commonly encountered in clinical practice, may be cancer‐
related, namely resulting from nervous system tumor invasion, surgical nerve damage …

Mechanisms of cancer-induced bone pain

T Middlemiss, BJA Laird, MT Fallon - Clinical Oncology, 2011 - Elsevier
Cancer-induced bone pain (CIBP) is common and challenging to treat. Common therapies,
such as opioids, radiotherapy and bisphosphonates, are often only partially effective. CIBP …

Randomized double-blind trial of pregabalin versus placebo in conjunction with palliative radiotherapy for cancer-induced bone pain

M Fallon, PJ Hoskin, LA Colvin… - Journal of Clinical …, 2016 - ascopubs.org
Purpose Cancer-induced bone pain (CIBP) affects one third of patients with cancer.
Radiotherapy remains the gold-standard treatment; however, laboratory and clinical work …

Neuropathic cancer pain: What we are dealing with? How to manage it?

E Esin, S Yalcin - OncoTargets and therapy, 2014 - Taylor & Francis
Cancer pain is a serious health problem, and imposes a great burden on the lives of patients
and their families. Pain can be associated with delay in treatment, denial of treatment, or …

[PDF][PDF] Intrathecal injection of metabotropic glutamate receptor subtype 3 and 5 agonist/antagonist attenuates bone cancer pain by inhibition of spinal astrocyte …

B Ren, X Gu, Y Zheng, C Liu, D Wang, Y Sun… - …, 2012 - scholar.archive.org
Background: Astrocytes and metabotropic glutamate receptors play important roles in
nociceptive processing. However, their roles in bone cancer pain were not well understood …

Targeting A-type K+ channels in primary sensory neurons for bone cancer pain in a rat model

KZ Duan, Q Xu, XM Zhang, ZQ Zhao, YA Mei… - Pain, 2012 - journals.lww.com
Bone cancer induced dynamic changes of A-type K+ channels in dorsal root ganglion
neurons. Diclofenac antagonized bone cancer pain by upregulating peripheral A-type K+ …

Increased expression of tetrodotoxin-resistant sodium channels Nav1. 8 and Nav1. 9 within dorsal root ganglia in a rat model of bone cancer pain

F Qiu, Y Jiang, H Zhang, Y Liu, W Mi - Neuroscience letters, 2012 - Elsevier
In attempt to understand the underlying mechanisms of cancer-induced bone pain, we
investigated the presence of two tetrodotoxin-resistant sodium channels, Nav1. 8 (SNS/PN3) …